Mark Dixon
Impact in
- Periodontics top 0.5%
- Oral microbiology and periodontitis research
- Oral Health Pathology and Treatment
- Immunology top 10%
- Immune Response and Inflammation
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Oncology 6
- CAR-T cell therapy research 3
- Viral-associated cancers and disorders 2
- Co-authors
- Derry C. Roopenian (6 shared papers)Pamela J. Baker (3 shared papers)R. T. Evans (3 shared papers)Ellis Johnson (1 shared paper)Peter Baker (3 shared papers)Andrew Davies (2 shared papers)A T Axon (1 shared paper)D M Chalmers (1 shared paper)
- Journals
- Blood (5 papers)Infection and Immunity (3 papers)Pacing and Clinical Electrophysiology (1 paper)Journal of Biopharmaceutical Statistics (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Mark Dixon
17 papers receiving 729 citations
Peers
Comparison fields: 5 of 72
- Periodontics 383
- Immunology 270
- Genetics 70
- Microbiology 40
- Pharmacy 31
Countries citing papers authored by Mark Dixon
This map shows the geographic impact of Mark Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dixon more than expected).
Fields of papers citing papers by Mark Dixon
This network shows the impact of papers produced by Mark Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dixon. The network helps show where Mark Dixon may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dixon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 273 | |
| 2 | 2000 | 138 | |
| 3 | 2017 | 83 | |
| 4 | 2000 | 67 | |
| 5 | 2020 | 44 | |
| 6 | 1998 | 41 | |
| 7 | 2000 | 37 | |
| 8 | 1999 | 28 | |
| 9 | 2015 | 11 | |
| 10 | 2024 | 10 | |
| 11 | 2014 | 10 | |
| 12 | 2014 | 6 | |
| 13 | 2022 | 4 | |
| 14 | 1995 | 2 | |
| 15 | Abstract 15282: Individual Participant Meta Analysis of the Cardiovascular Safety of Taspoglutide Among Individuals with Diabetes | 2012 | 1 |
| 16 | 2023 | 1 | |
| 17 | 2016 | 1 | |
| 18 | Genetic control of susceptibility to porphyromonas gingivalis-induced alveolar bone loss in mice [In Process Citation] | 2000 | 0 |
| 19 | 2019 | 0 |
About Mark Dixon
Mark Dixon is a scholar working on Pathology and Forensic Medicine, Oncology, Periodontics, Genetics and Pharmacy, having authored 19 papers that have together received 757 indexed citations. Recurring topics across this work include Oral microbiology and periodontitis research (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Oral and gingival health research (4 papers), CAR-T cell therapy research (3 papers), Oral Health Pathology and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Periodontics (383 citations), Immunology (270 citations), Genetics (70 citations), Microbiology (40 citations) and Pharmacy (31 citations). Mark Dixon has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Derry C. Roopenian, Pamela J. Baker, R. T. Evans, Ellis Johnson, Peter Baker, Andrew Davies, A T Axon, D M Chalmers, Francesco Merli and Noppadol Siritanaratkul. Their work appears in journals such as Blood, Infection and Immunity, Pacing and Clinical Electrophysiology, Journal of Biopharmaceutical Statistics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.